Padrutt, I <br/><br/>
Effects of the glucagon-like peptide-1 (GLP-1) analogues exenatide, exenatide extended-release, and of the dipeptidylpeptidase-4 (DPP-4) inhibitor sitagliptin on glucose metabolism in healthy cats.  [electronic resource] 

 -  Research in veterinary science  Apr 2015 
 - 23-9 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1532-2661 
<br/><br/><label>Standard No.: </label>10.1016/j.rvsc.2014.12.001  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Area Under Curve<br/>Cats--metabolism<br/>Exenatide<br/>Glucagon-Like Peptide 1--analogs & derivatives<br/>Glucose--metabolism<br/>Humans<br/>Incretins--pharmacology<br/>Insulin--metabolism<br/>Insulin Secretion<br/>Peptides--pharmacology<br/>Sitagliptin Phosphate--pharmacology<br/>Venoms--pharmacology